Company Filing History:
Years Active: 2019-2025
Title: Paul A Jaminet: Innovator in Antibody Conjugates
Introduction
Paul A Jaminet is a notable inventor based in Cambridge, MA, with a focus on advancements in antibody-oligonucleotide and antibody-drug conjugates. He holds a total of four patents, showcasing his contributions to the field of biotechnology.
Latest Patents
His latest patents include innovative conjugates that comprise a targeting protein, such as an anti-TM4SF1 antibody or antigen, along with methods of manufacture and use. Additionally, he has developed antibody-drug conjugates that incorporate anti-TM4SF1 antibodies, detailing methods for their application.
Career Highlights
Throughout his career, Paul has worked with prominent companies, including Angiex, Inc. and Refinitiv US Organization LLC. His work has significantly impacted the development of therapeutic strategies in the biomedical field.
Collaborations
Paul has collaborated with esteemed colleagues, including Shou-Ching S Jaminet and Leonard G Presta, contributing to a rich exchange of ideas and innovations.
Conclusion
Paul A Jaminet's work in the realm of antibody conjugates exemplifies his commitment to advancing medical science through innovative inventions. His contributions continue to influence the biotechnology landscape.